Meeting/Event

Bioethics Issues in Neuroscience Research on Drug Abuse

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA).
View current meetings on nida.nih.gov.

Details

Neuroscience Center, Rockville, Maryland

Contact

United States

Meeting Summary

by Dr. LeRoy Walters, Director, Kennedy Institute of Ethics, Georgetown University and Dr. Christine Grady, acting Director, Department of Bioethics, NIH Clinical Center.

First, Dr. Grady discussed the seven ethical requirements that provide a framework for determining whether clinical research meets universal, necessary and sufficient ethical values. These seven criteria are:

  1. social or scientific value,
  2. scientific validity,
  3. fair subject selection,
  4. favorable risk-benefit ratio,
  5. independent review,
  6. informed consent, and
  7. respect for potential and enrolled subjects.

Dr. Walters then discussed the U.of Pennsylvania gene therapy experiment in which Jesse Gelsinger died. Dr. Walters suggested that because both gene transfer and xenograft research are in the early stages of their development, they require special oversight.